Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE American - Delayed Quote USD

NovaBay Pharmaceuticals, Inc. (NBY)

Compare
0.5623
-0.0097
(-1.70%)
At close: April 3 at 4:00:00 PM EDT
0.5500
-0.01
(-2.19%)
After hours: April 3 at 6:27:57 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Justin M. Hall Esq. President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director 364.15k -- 1978
Mr. Tommy Law Controller, Interim CFO & Treasurer 177.7k -- 1985

NovaBay Pharmaceuticals, Inc.

2000 Powell Street
Suite 1150, eleventh floor
EmeryVille, CA 94608
United States
510 899 8800 https://novabay.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Corporate Governance

NovaBay Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 7, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

NovaBay Pharmaceuticals, Inc. Earnings Date

Recent Events

April 2, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

April 1, 2025 at 12:00 AM UTC

NT 10-K: Periodic Financial Reports

March 19, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 7, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

February 4, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 30, 2025 at 7:00 PM UTC

Extraordinary Shareholders Meeting

January 23, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

January 22, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 10, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers